Evidence map›Paper›PMID 40416939›Full record

ArticleBiomaterials research2025

Effect of Mechanical Environment Alterations in 3D Stem Cell Culture on the Therapeutic Potential of Extracellular Vesicles.

Wu Young Kang, Sunyoung Jung, Hyundoo Jeong, Hyun-Myung Woo, Min-Ho Kang, Hojae Bae, Jae Min Cha

Abstract read
In one paragraph

Article in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Wu Young KangDepartment of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.
Sunyoung JungDepartment of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.
Hyundoo JeongDepartment of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.
Hyun-Myung WooDepartment of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.
Min-Ho KangDepartment of BioMedical-Chemical Engineering (BMCE), The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Hojae BaeDepartment of Stem Cell and Regenerative Biotechnology, KU Convergence Science and Technology Institute, Konkuk University, Seoul 05029, Republic of Korea.
Jae Min ChaDepartment of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.ORCID https://orcid.org/0000-0002-8713-2078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem-cell-derived extracellular vesicles (EVs) have emerged as a promising therapeutic option, addressing the limitations of conventional stem cell therapies. However, the variability and poorly defined therapeutic contents of EVs produced under standard 2-dimensional culture conditions present challenges for their clinical application. In this study, we investigated how the therapeutic properties of mesenchymal stem cell (MSC)-derived EVs can be enhanced by culturing MSCs within 3-dimensional hydrogels that have tunable mechanical properties. Our results demonstrate that different mechanical cues from the culture environment can induce specific gene expression changes in MSCs without compromising their inherent characteristics. Furthermore, EVs derived from these MSCs exhibited distinct angiogenic and immunomodulatory activities, which were dependent on the mechanical properties of the hydrogels used. A comprehensive analysis of the cytokines and microRNAs present in the EVs provided additional validation of these findings. By utilizing a noninvasive culture method that eliminates the need for genetic modification or exogenous biochemical supplementation, our approach presents a novel platform for the tailored production of EVs, thereby enhancing their therapeutic potential in regenerative medicine.

Identifiers

PMID40416939
PMCPMC12099057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.